Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products it ships into the United States are offset by its exports of U.S.-made drugs ...

Roche delivered a somewhat underwhelming first quarter as the growth of its key pharma products has stalled and as the diagnostics division faces pricing headwinds in China. However, I see no ...

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030. According to a news release from the company. the site will serve as a hub for ...

"Integrating the SBX technology into clinical and translational pipelines opens exciting new possibilities,” said Niall ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

Furthermore, ~25% of Roche's business is diagnostics, and it's unclear if this would be as badly affected by tariffs as pharmaceutical drug products - my suspicion would be diagnostics products ...

Roche’s head of diagnostics global operations. “This location has strong manufacturing capabilities and a long-standing history of producing diabetes care products for Roche. In fact ...

Roche Diagnostics will invest $550 million in its ... capabilities and a longstanding history of producing diabetes care products for Roche." The investment is part of a larger $50 billion ...

Roche Diagnostics’ North American division ... Before the Trump administration backed off its most stringent tariff plans, products imported from Switzerland had been set to face tariffs ...

Swiss drug giant Roche has further cemented its ... both national and international, for our products and services in the cancer-diagnostics arena," Ventana President Hany Massarany said during ...